Full Text PA-95-090 OLFACTORY NEUROGENESIS NIH GUIDE, Volume 24, Number 33, September 22, 1995 PA NUMBER: PA-95-090 P.T. 34 Keywords: 0775017 Biology, Cellular 0705048 National Institute on Deafness and Other Communication Disorders National Institute on Aging PURPOSE This program announcement reiterates the continuing interest of the National Institute on Deafness and Other Communication Disorders (NIDCD) and the National Institute on Aging (NIA) in receiving applications for the study of the mechanisms that maintain, terminate, and reinitiate the sequence of olfactory neurogenesis in the olfactory epithelium throughout the life of the organism. The scope of this program announcement (PA) includes the neurogenic sequence of cell proliferation, differentiation, synaptogenesis, growth, migration, maturation, cell death, and the mitotic signals to renew the cycle under both normal physiologic conditions and after experimental procedures, such as olfactory nerve transection, that perturb this unique cycle of neural development. This PA is timely because the recent development of molecular tools makes the identification of specific types of sensory neurons and their connections practical. This announcement supplements a previous one, Nasal Chemoreception: Regeneration and Trophic Interactions (NIH Guide, Vol. 18, No. 34, September 29, 1989), and is part of the NIDCD programmatic theme of sensory regeneration in the auditory, vestibular, and chemosensory systems. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This PA, Olfactory Neurogenesis, is related to the priority areas of diabetes and chronic disabling conditions and special population objectives. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-11474-0 or Summary Report: Stock No. 017-001-11473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-512-1800). ELIGIBILITY REQUIREMENTS Applications may be submitted by domestic and foreign, for-profit and non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the Federal government. Applications from minority individuals, women, and individuals with disabilities are encouraged. Foreign institutions are not eligible for First Independent Research Support and Transition (FIRST) (R29) awards. MECHANISM OF SUPPORT The support mechanisms for grants in this area will be the research project grant (R01) and the FIRST (R29) award. RESEARCH OBJECTIVES Olfactory sensory neurons are the only mammalian projection neurons that are known to be continuously replaced during adult life. These neurons develop from precursor cells in the olfactory epithelium both under normal physiologic conditions and after various experimental procedures, such as chemical exposure and naris closure, that change the rate of cell division. These exceptional neurons can reestablish functional synaptic connections with their target cells in the olfactory bulb. No other neuron retains its ability to grow from the periphery into the central nervous system in adulthood. This suggests that olfactory sensory neurons must express the right receptor molecules and match that expression to the right targets in the olfactory bulb, not only during initial development, but also during subsequent neurogenesis. These features provide a unique model system for the study of certain aspects of neural development and cell replacement in the adult animal. In addition, recent studies of neural development suggest that many neuronal precursors are multipotent and ultimately adopt a neuronal fate on the basis of local environmental factors. It is possible that progenitors of olfactory sensory neurons in the olfactory epithelium are multipotent. These progenitors might ultimately serve as a source of neurons to replace neurons lost from other parts of the nervous system as a result of aging, neurodegenerative diseases, and injury. Many aspects of the cellular and molecular mechanisms of olfactory neurogenesis need to be investigated, including the regulation of gene expression, a process central to understanding neurogenesis. Substantial opportunities exist to address these issues through the application of contemporary molecular biologic, molecular genetic, and biotechnologic tools that make the identification of specific types of receptor neurons and their connections practical. Examples of possible research topics are listed below. Investigators are encouraged to address these or other issues relevant to the understanding of the cellular and molecular mechanisms of olfactory neurogenesis. o Define the lineage of the olfactory sensory neuron. Characterize the olfactory stem cell and the intermediate cell forms in olfactory neurogenesis. o Determine the role of macrophages in cell proliferation. Determine how transcription factors control cell proliferation. o Characterize the mechanisms of cell signaling critical to the determination of the fate of olfactory cells. o Investigate the mitogenic protein growth factors required for genesis of neurons and of supporting cells in the olfactory epithelium. Investigate the trophic factors necessary for survival of each of these types of cells. Determine the relationship between these two types of cells. o Search for tropic molecules that may be involved in olfactory axon pathfinding. Determine the role of glial cells in this pathfinding. o Identify the signals and response mechanism leading to cessation of axonal growth and formation of a functional synapse. o Determine whether all or only some olfactory sensory neurons undergo programmed cell death. Characterize the mechanisms that regulate any such apoptosis. Identify the molecules associated with apoptosis and with necrosis. o Determine how an equilibrium between cell birth and cell death is maintained in the olfactory epithelium. Identify the mechanisms of upregulation and downregulation of cell birth and cell death. o Determine whether olfactory neuron precursors are multipotent. Examine how the cell's environment influences the fate of olfactory epithelial cells. o Characterize and identify mechanisms responsible for changes occurring in olfactory neurogenesis as a function of age of the organism. o Characterize and identify mechanisms of differential effectiveness of specific trophic or growth factors in aging vs. developing animals. o Characterize and identify mechanisms of aging-related altered responsiveness of olfactory epithelium to injury or disease. Novel approaches to address the cellular and molecular mechanisms of olfactory neurogenesis are encouraged. Examples of approaches that can be used to study olfactory neurogenesis include, but are not limited to, those below. o Retroviral techniques and specific dyes to label olfactory cell types. o Organotypic and cell culture models to characterize and manipulate the cells, molecules, and genes that determine olfactory neurogenesis. o Genetically modified cell lines and transgenic animals to permit identification of factors and genes involved in olfactory neurogenesis. o Cell transplants for the study of olfactory neurogenesis in the developing and adult nervous system. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This new policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43) and supersedes and strengthens the previous policies (Concerning the Inclusion of Women in Study Populations, and Concerning the Inclusion of Minorities in Study Populations), which have been in effect since 1990. The new policy contains some provisions that are substantially different from the 1990 policies. All investigators proposing research involving human subjects should read the "NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research," which was reprinted in the Federal Register of March 28, 1994 (FR 59 14508-14513) to correct typesetting and errors in the earlier publication, and reprinted in the NIH GUIDE FOR GRANTS AND CONTRACTS of March 18, 1994. Volume 23, Number 11, March 18, 1994. Investigators also may obtain copies of the policy from the program staff listed under INQUIRIES. Program staff may also provide additional relevant information concerning the policy. APPLICATION PROCEDURES Applications are to be submitted on the grant application form PHS 398 (rev. 5/95) and will be accepted at the standard application deadlines as indicated in the application kit. Application kits are available from most institutional offices of sponsored research and may be obtained from the Office of Grants Information, Division of Research Grants, National Institutes of Health, 6701 Rockledge Drive, MSC 7762, Bethesda, MD 20892-7762, telephone (301) 710-0267, email: girg@drgpo.drg.nih.gov. The title and number of the program announcement must be typed in Section 2 on the face page of the application. Applications for the FIRST Award (R29) must include at least three sealed letters of reference attached to the face page of the original application. FIRST Award (R29) applications submitted without the required number of reference letters will be considered incomplete and will be returned without review. The completed original application and five legible copies must be sent or delivered to: DIVISION OF RESEARCH GRANTS NATIONAL INSTITUTES OF HEALTH 6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710 BETHESDA, MD 20892-7710 BETHESDA, MD 20817-7710 (express/courier service) REVIEW CONSIDERATIONS Applications will be assigned on the basis of established PHS referral guidelines. Applications will be reviewed for scientific and technical merit by an appropriate Initial Review Group within the Division of Research Grants, NIH, in accordance with the standard NIH peer review procedures. Following scientific-technical review, the applications will receive a second-level review by the appropriate national advisory council. Applications that are complete will be evaluated for scientific and technical merit by an appropriate peer review group convened in accordance with the standard NIH peer review procedures. As part of the initial merit review, all applications will receive a written critique and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed, assigned a priority score, and receive a second level review by the appropriate national advisory council or board. AWARD CRITERIA Applications will compete for available funds with all other applications assigned to that Institute. The following will be considered in making funding decisions: o Quality of the proposed project as determined by peer review o Availability of funds o Program priorities among research areas of the program announcement INQUIRIES Written and telephone inquiries concerning this PA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to: Jack Pearl, Ph.D. Division of Human Communication National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-C 6120 Executive Boulevard MSC 7180 Bethesda, MD 20892-7180 Telephone: (301)-402-3464 FAX: (301)-402-6251 Email: Jack_Pearl@nih.gov Judith A. Finkelstein, Ph.D. Neuroscience and Neuropsychology of Aging Program National Institute on Aging Gateway Building, Suite 3C307 7201 Wisconsin Avenue, MSC 9205 Bethesda, MD 20892-9205 Telephone: (301)496-9350 FAX: (301)496-1494 Email: FinkelsJ@gw.nia.nih.gov Direct inquiries regarding fiscal matters to: Sharon Hunt Division of Extramural Activities National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-B 6120 Executive Boulevard, MSC 7180 Bethesda, MD 20892-7180 Telephone: (301) 402-0909 FAX: (301) 402-1758 Email: SH79F@Nih.Gov Joseph Ellis Grants and Contracts Management Office National Institute on Aging Gateway Building, Suite 2N212 7201 Wisconsin Avenue, MSC-9205 Bethesda, MD 20892-9205 Telephone: (301) 496-1472 FAX: (301) 402-3672 Email: EllisJ@gw.nia.nih.gov AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance Nos. 93.173 and 93.866. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-410, as amended by Public Law 99-158, 42 USC 241 and 285) and administered under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The PHS strongly encourages all grant and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. .
Return to NIH Guide Main Index
![]() |
Office of Extramural Research (OER) |
![]() |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||